The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
| Factor | Score | Distribution | Value | Avg | Rank |
|---|---|---|---|---|---|
Valuation | 65 | 15.1x | 20.8x | Around median | |
Growth | 20 | -1.1% | 6.1% | Bottom tier | |
Quality | 60 | 41.8% | 6.6% | Around median | |
Safety | 44 | 2.0x | 0.7x | Around median | |
Capital Return | 56 | 5.75% | 2.02% | Around median | |
Momentum | 87 | 19.5% | 4.1% | Top tier | |
Sentiment | 78 | 8 | 3 | Top tier |
Estimates — analyst targets and a simplified DCF, not investment advice.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.
Altria Group, Inc. is considered one of the leading major companies in the tobacco and smoke-free alternative products sector in the United States, with its business primarily focused on manufacturing and marketing traditional cigarettes, oral tobacco products, and innovative nicotine solutions. The Group's portfolio includes dominant brands such as Marlboro in the premium cigarette category, Copenhagen and on! in the oral tobacco and nicotine pouch sector, alongside significant strategic investments including a minority stake in Anheuser-Busch InBev (ABI). The company relies on a highly cash-generative business model to support its business growth and deliver rewarding returns to shareholders.
During the first quarter of 2026, Altria Group achieved strong financial results, with total revenues reaching $5.4 billion, gross profit of $3.5 billion, and net income of $2.2 billion, resulting in earnings per share of $1.3. The smokeable products segment demonstrated clear resilience with adjusted operating companies income (OCI) growing by 6.3% to reach an operating income margin of 65.1%, supported by a 6.3% increase in net pricing. Meanwhile, the oral tobacco products segment achieved adjusted operating income exceeding $400 million with a strong margin of 67.4%, despite being temporarily impacted by marketing investments for the Group's subsidiary, Helix.
Altria Group enjoys a general analyst consensus recommending a 'Buy', with an average price target of $71.83, a maximum forecast of up to $77, and a minimum of $64. The stock currently trades below the analysts' average price target, reflecting an attractive valuation for investors considering the company's ongoing commitment to share repurchases and reducing its leverage to reach a debt-to-EBITDA ratio of 1.9 times.
Figures in the text are as of 2026-06-15; the live price is shown at the top of the page.
In the first quarter of 2026, Altria Group recorded revenues of $5.4 billion, with a gross profit of $3.5 billion and net income of $2.2 billion, resulting in earnings per share of $1.3. The company also successfully increased its adjusted diluted earnings per share by 7.3% during the quarter. This performance was supported by the resilience of the smokeable products segment, which achieved a 6.3% increase in net pricing and an expansion in the adjusted operating companies income margin to reach 65.1%.
The on! portfolio experienced strong growth as shipment volumes rose by nearly 18% to exceed 46 million cans in the first quarter of 2026, driven by the national marketing of the on! PLUS product, which launched in March 2026 and became available in 100,000 stores. Together, the share of the on! and on! PLUS brands represents approximately 7.8% of the total retail oral tobacco category, recording a sequential increase of 0.2 percentage points compared to the previous quarter. The company is currently awaiting U.S. Food and Drug Administration (FDA) approval for additional flavor authorization applications under its expedited pilot program.
Automated analysis for informational purposes only — not investment advice.
Altria Group reaffirmed its full-year 2026 adjusted diluted earnings per share guidance to range between $5.56 and $5.72, representing a growth of 2.5% to 5.5% compared to the $5.42 recorded in 2025. Management now expects this growth to be more balanced between the first and second halves of the year, thanks to strong operational performance in the first quarter. This guidance takes into account ongoing economic challenges facing consumers and the impact of slowing growth of illicit e-cigarettes.
Although PM USA's domestic cigarette shipment volume declined by an adjusted 4% in the first quarter, this decline was better than expected and showed continued sequential moderation. The company is addressing consumer trade-down to lower-cost products due to economic pressures through its total portfolio strategy, successfully increasing the market share of its discount brand Basic by 2.4 percentage points year-over-year. Meanwhile, the Marlboro brand maintains its strength in the premium segment with a 59.5% share, and the company plans to expand the distribution of the Cowboy Cut product in the second quarter to provide additional competitive options.
Altria Group returned substantial cash to shareholders during the first quarter of 2026, amounting to approximately $1.8 billion in cash dividends, alongside repurchasing 4.5 million shares for $280 million, with $72 million remaining under the current repurchase program that expires at the end of the year. The company also strengthened its balance sheet by paying off $1 billion in maturing debt in February 2026. The total debt-to-EBITDA ratio stood at approximately 1.9 times, which is fully aligned with the company's strategic targets.